Case Review Form

      * Denotes required field.


      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address




      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Jury Asked to Award $5.3M to Actos Bladder Cancer Victim

Filed April 17th, 2013 edlieber1


The jury hearing the first Actos bladder cancer case in the U.S. was told they should award the plaintiff, Jack Cooper, a total of $5.3 million in damages for the terminal injuries he’s incurred because of the disease.

According to a report, an attorney representing Cooper said during closing arguments at the trial in Los Angeles that the award he’s requesting actually lets Takeda Pharmaceuticals “off pretty easy” considering his client’s grave condition.

Cooper’s case centers on the theory that Takeda has known since 2004 that its top-selling Type 2 diabetes drug, Actos, could significantly increase the risk that a person will develop bladder cancer, especially when the drug is taken for more than a year, but the company failed to warn the public. During the trial, internal Takeda emails have been presented in which top company officials are shown debating the impact of a warning label on Actos that mentions the risk of bladder cancer.

We’ve previously reported that in June 2011, the U.S. Food and Drug Administration announced that using Actos for more than a year could increase a person’s risk of developing bladder cancer.

Cooper was diagnosed with bladder cancer in December 2011 and is not expected to survive through this year, according to the report.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!